NCT00243477View on ClinicalTrials.gov

MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting

PHASE4CompletedINTERVENTIONAL
Enrollment

368

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2011

Study Completion Date

February 29, 2012

Conditions
Coronary Artery Disease
Interventions
DRUG

Escitalopram

Escitalopram 10mg or placebo once a day

Trial Locations (1)

25000

Sidney Chocron, Besançon

All Listed Sponsors
collaborator

H. Lundbeck A/S

INDUSTRY

lead

Hopital Jean Minjoz

OTHER

NCT00243477 - MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting | Biotech Hunter | Biotech Hunter